Kite Pharma Expands Collaboration With Netherlands Cancer Institute (NKI)
14 sept. 2015 08h00 HE
|
Kite Pharma, Inc.
SANTA MONICA, Calif., Sept. 14, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Kite) (Nasdaq:KITE) today announced that it has expanded its collaboration with the Netherlands Cancer Institute (NKI). Kite...
Kite Pharma Receives Positive Opinion for Orphan Drug Designation in the European Union for KTE-C19, Kite's Lead Cancer T-Cell Immunotherapy
11 sept. 2015 08h00 HE
|
Kite Pharma, Inc.
SANTA MONICA, Calif., Sept. 11, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Kite) (Nasdaq:KITE) announced that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has...
Kite Pharma Commends Honors Conferred to Scientific Advisory Board Members for Their Significant Contributions to Medicine
03 sept. 2015 16h19 HE
|
Kite Pharma, Inc.
Kite SAB Chair Dr. Owen Witte Reappointed to US Cancer Panel
Prof. Zelig Eshhar Received Israel Prize, the Nation's Highest Honor
Dr. James Economou Elected to the National Academy of...
Kite Pharma to Participate in Upcoming Investor Conferences in September 2015
03 sept. 2015 08h00 HE
|
Kite Pharma, Inc.
SANTA MONICA, Calif., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE) today announced that the management team will participate in two upcoming investor conferences this...
Kite Pharma Provides Update on KTE-C19 Clinical Trial
17 août 2015 08h00 HE
|
Kite Pharma, Inc.
Kite KTE-C19 Trial on Track to Advance to Pivotal Phase 2
Kite to Host Conference Call and Webcast on August 17, 2015 at 9:00am Eastern Time
SANTA MONICA, Calif., Aug. 17, 2015 (GLOBE NEWSWIRE)...
Kite Pharma to Hold Conference Call to Provide a Corporate Update on Monday, August 17, 2015
14 août 2015 16h30 HE
|
Kite Pharma, Inc.
SANTA MONICA, Calif., Aug. 14, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Kite) (Nasdaq:KITE) today announced that it will host a live conference call on Monday, August 17, 2015, at 9:00am Eastern...
Kite Pharma Reports Second Quarter 2015 Financial Results
10 août 2015 16h00 HE
|
Kite Pharma, Inc.
SANTA MONICA, Calif., Aug. 10, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Kite) (Nasdaq:KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy...
Kite Pharma to Host Second Quarter 2015 Financial Results Conference Call and Webcast
06 août 2015 08h00 HE
|
Kite Pharma, Inc.
SANTA MONICA, Calif., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Nasdaq:KITE) today announced that management will host a conference call and live webcast discussion at 4:30 p.m. Eastern Time...
Kite Pharma to Present at the Canaccord Genuity 35th Annual Growth Conference
05 août 2015 08h00 HE
|
Kite Pharma, Inc.
SANTA MONICA, Calif., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Nasdaq:KITE) today announced that management will present a company overview at the Canaccord Genuity 35th Annual Growth...
Kite Pharma and The Leukemia & Lymphoma Society(R) Enter Into Collaboration to Enhance the Development of KTE-C19 in Refractory Aggressive Non-Hodgkin Lymphoma and Launch CAR T-Cell Therapy Educational Programs
01 juil. 2015 08h00 HE
|
Kite Pharma, Inc.
SANTA MONICA, Calif. and WHITE PLAINS, N.Y., July 1, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE) and The Leukemia & Lymphoma Society (LLS) announced today that they have entered into...